Clinical Trial Update: A Trial of RAD001/Capecitabine in Refractory Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the combination of everolimus (RAD001) and capecitabine in refractory/metastatic gastric cancer. The document provides tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Everolimus (everolimus)

Snippet

Sponsor: Samsung Medical Center | Conditions: Metastatic Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED